Comorbidities in ADHD children treated with methylphenidate: a database study

BACKGROUND: Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorder (ADHD) in children. Treatment with MPH is contraindicated in the presence of certain psychiatric, cerebro- and cardiovascular conditions. We assessed MPH treatment prevalence and inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraut, Angela A, Langner, Ingo, Lindemann, Christina, Banaschewski, Tobias, Petermann, Ulrike, Petermann, Franz, Mikolajczyk, Rafael T, Garbe, Edeltraut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544568/
https://www.ncbi.nlm.nih.gov/pubmed/23294623
http://dx.doi.org/10.1186/1471-244X-13-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544568/
https://www.ncbi.nlm.nih.gov/pubmed/23294623
http://dx.doi.org/10.1186/1471-244X-13-11

Ejemplares similares